Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 9ER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03141177
Recruitment Status : Active, not recruiting
First Posted : May 4, 2017
Last Update Posted : February 12, 2021
Sponsor:
Collaborators:
Exelixis
Ono Pharmaceutical Co. Ltd
Information provided by (Responsible Party):
Bristol-Myers Squibb